Comparison between pediatricians and family practitioners in the use of the prokinetic cisapride for gastroesophageal reflux disease in children

Pediatrics

Volumn 109, Issue 6, 2002, Pages 1118-1123

  Shaoul, Ron ^a   Shahory, Ron ^a,b   Tamir, Ada ^a,b   Jaffe, Michael ^b  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Children; Cisapride; Family practitioners; Gastroesophageal reflux; Pediatricians

Indexed keywords

CISAPRIDE;

ARTICLE; CARDIOTOXICITY; DRUG MISUSE; GASTROESOPHAGEAL REFLUX; GENERAL PRACTITIONER; HUMAN; ISRAEL; PEDIATRICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QT INTERVAL; QUESTIONNAIRE;

CISAPRIDE; CLINICAL COMPETENCE; FAMILY PRACTICE; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; ISRAEL; MALE; MIDDLE AGED; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 0036263965     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.109.6.1118     Document Type: Article

References (43)

1. Gastroesophageal reflux
2. Gastroesophageal reflux in infants and children
3. Gastroesophageal reflux disease in children
4. A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: A report from a working group on gastro-oesophageal reflux disease
5. Current concepts and issues in the management of regurgitation of infants: A reappraisal. Management guidelines from a working party
6. Nutritional management of regurgitation in infants
7. The role of cisapride in the treatment of pediatric gastroesophageal reflux
8. Cisapride: A survey of the frequency of use and adverse events in premature newborns
9. The use of cisapride in children
10. UK licence for cisapride suspended
11. Diagnosis and treatment of gastro-oesophageal reflux disease in infants and children
12. Cisapride in the control of symptoms in infants with gastroesophageal reflux: A randomized, double-blind, placebo-controlled trial
13. Cisapride in pediatric gastroesophageal reflux
14. (In)Efficacy of cisapride
15. Cisapride doesn't work? Don't go breakin' my heart!
16. The efficacy of cisapride: Time to review not regurgitate
17. The efficacy of cisapride: What is needed for digestion?
18. Prolongation of the QT interval and the sudden infant death syndrome
19. Proarrhythmia associated with cisapride in children
20. Effects of cisapride on QT interval in children
21. Effect of cisapride on the QT interval in infants with gastroesophageal reflux
22. The relationship between gastroesophageal reflux and apnea in infants
23. Gastroesophageal reflux and infant apnea
24. Gastroesophageal reflux and sudden infant death syndrome
25. The risk of sudden infant death from gastroesophageal reflux
26. Regurgitation and sudden infant death syndrome
27. Cisapride guidelines
28. Clinical use of cisapride and its risk-benefit in paediatric patients
29. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I
30. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II
31. Incidence of adverse drug events and potential adverse drug events. Implications for prevention
32. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction
33. Assessment of healthcare professionals' knowledge about warfarin-vitamin K drug-nutrient interactions
34. Prescription of non-steroidal anti-inflammatory agents and risk of iatrogenic adverse effects: A survey of 1072 French general practitioners
35. Are prescribing patterns of diuretics in general practice good enough? A report from the More & Romsdal Prescription Study
36. Psychotropic drug therapy knowledge of health care practitioners
37. Physicians' knowledge of antidepressant withdrawal effects: A survey
38. One-to-one versus group sessions to improve prescription in primary care: A pragmatic randomized controlled trial
39. From trial data to practical knowledge: Qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia
40. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors
41. Medication error prevention by clinical pharmacists in two children's hospitals
42. Effect of computer-based alerts on the treatment and outcomes of hospitalized patients
43. Physicians' assessment of computerized prescribing